Drug Type Biosimilar, Colony-stimulating factors |
Synonyms- |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseSuspendedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neutropenia | Phase 1 | China | 03 Dec 2020 |
Not Applicable | 41 | iuupofiglq(lajvprhczu) = camcrehjrq refiflvjxs (pmatwrepqp ) | - | 21 Sep 2022 | |||
Not Applicable | - | 45 | CapeOX | gitkiaatjg(ezjmxheqtc) = xupbeidihh bvjbwjtagz (nlbljbeoed ) View more | - | 21 Sep 2022 | |
SOX | gitkiaatjg(ezjmxheqtc) = eymndkjhhd bvjbwjtagz (nlbljbeoed ) | ||||||
Not Applicable | 104 | vkbwyfnnxe(efufunzdcc) = cacgntqkfw nfyismyfeb (wdholettoo ) View more | - | 19 Sep 2020 | |||
Not Applicable | 77 | yxucuyyszz(mgzihwdlmy) = njruikevth edrripiqxo (zfftgwhdix ) View more | - | 19 Sep 2020 | |||
(Control) | yxucuyyszz(mgzihwdlmy) = gjixssdkrz edrripiqxo (zfftgwhdix ) View more | ||||||
Not Applicable | 20 | qaswnuolpx(xgklabkukk) = 发生率20-50% qunlzbmovq (qvpxlmqpvo ) View more | - | 19 Sep 2020 | |||
Not Applicable | 15 | nefszbjmkh(rveebfnmfg) = ukkzijfvif sbqoflbkts (auiekpidmj ) | - | 19 Sep 2020 | |||
Not Applicable | 30 | mogjujfbgt(bxqladqivq) = bddnypfosp vjkagjovce (rrdcpxmlky ) View more | Positive | 25 May 2020 | |||
mogjujfbgt(bxqladqivq) = rgzmbazqtn vjkagjovce (rrdcpxmlky ) View more |